CD4 and Parkinson disease: In an animal model, the production of pro-inflammatory factors and CD4+/CD8+ T-cell infiltration in the substantia nigra was reduced by administration of anti-CCL11 neutralizing antibody, prevented ameliorated motor symptoms and nigrostriatal neurodegeneration in PD mice (113), indicating a potential mechanism of CCL11 in PD.